OMX Nordic 40 Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | AZN | AstraZeneca PLC ADR | (0.24) | 1.50 | (0.36) | ||
| 2 | EQT | EQT Corporation | 0.25 | 2.15 | 0.53 | ||
| 3 | GMAB | Genmab AS | (0.24) | 1.52 | (0.37) | ||
| 4 | SAND | Sandstorm Gold Ltd | 0.03 | 2.31 | 0.08 | ||
| 5 | EVO | Evotec SE ADR | 0.11 | 5.68 | 0.64 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.